Zoono Group are leading experts in antimicrobial protection, listed on the Australian Stock Exchange (ASX:ZNO).
Zoono specialises in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions.
Over the past 5 years, Zoono has developed a suite of proven products that enable our customer’s partners and distributors to realise and maximise both revenue producing and commercial opportunities.
Zoono Group has developed, and owns, a wealth of intellectual property based around the ‘Zoono Molecule’. A unique, antimicrobial technology that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. It has proven efficacy and longevity, it does not leach and cannot diminish in strength.
Today, Zoono Group has established a global network of customers and distributors that are spread across 42 countries and territories.
As the market leader in its field, Zoono Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.
WHAT MAKES US UNIQUE?
We are the leaders in a technological shift in antimicrobial technologies. Zoono’s unique technology is unlike anything else available.
- Kills 99.99% of germs and protects long after the product is applied
- Ultra Gentle
- Proven by over 100 independent laboratories
Built on a strong foundation of research, Zoono conforms to regulations from around the world and has passed EN14476, EN14476+A2:2019, PAS:2424, EN13697, EN1276 and EN1650 amongst many more antimicrobial efficacy tests.
Zoono is dedicated to providing a range of highly effective antimicrobial products.
Zoono products have a gentle formulation, are water-based and use a physical kill which reduces the need for harsh chemicals.
A true technological revolution.
Zoono is an innovative new version of an active which has been trusted by health professionals for decades.
Social Media & Operations Supervisor (NZ)
Director International Sales (NZ)
Global Managing Director / CEO (NZ)
Chief Financial Officer (NZ)
Marketing Manager (NZ)
Chief Operating Officer (NZ)
Business Development (Korea and Canada)
Regional Manager (UK)
Business Development (Singapore)
Business Development (China)
Zoono’s head office is in New Zealand. Manufacturing facilities are located in New Zealand and the United States of America. Authorised Zoono representatives are available around the world to assist your requirements.
In 2008 Paul knew he held onto advanced antimicrobial technology that could have the potential to drastically improve the lives of billions around the world. Today he speaks proudly about Zoono, the new range for consumers and the evidence supporting Zoono’s effectiveness which come in the form of independent laboratory testing that Zoono has been collecting since the beginning.